Health Condition 1: E11- Type 2 diabetes mellitus
Conditions
Interventions
Intervention1: nil: nil
Control Intervention1: nil: nil
Sponsors
Dr Jagriti Nandwani
Eligibility
Inclusion criteria
Inclusion criteria: 1) Willingness to provide voluntary informed consent 2) For diabetic participants, confirmed diagnosis of diabetes mellitus (Type 2) according to American Diabetes Association diagnostic criteria : HbA1C greater than or equal to 6.5% 3) For non-diabetic participants, No history of diabetes mellitus : HbA1C less than 6.5%
Exclusion criteria
Exclusion criteria: 1) Pregnancy or lactation 2) Presence of any acute illness muscle disease like muscular dystrophy or myopathies, or electrolyte abnormalities that may affect metabolic parameters or phase angle 3) Use of medications known to significantly alter metabolic parameters or body composition (e.g., corticosteroids, antiretroviral drugs, diuretics, lithium and chemotherapy agents) 4) History of major surgeries within the past six months 5) Presence of implanted medical devices (pacemakers, defibrillators, or neurostimulators) that may interfere with bioelectrical impedance analysis (BIA) measurements 6) Any condition affecting fluid distribution (e.g., severe edema, ascites, congestive heart failure)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Phase angle is lower in patients with type 2 diabetes mellitus compared to non-diabeticsTimepoint: 15 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Diabetes related complications are associated with lower phase angleTimepoint: 15 months | — |
Countries
India
Contacts
Public ContactDr Dheeraj Kapoor
Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute
Outcome results
None listed